Viewing Study NCT00203866


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-03 @ 2:20 AM
Study NCT ID: NCT00203866
Status: TERMINATED
Last Update Posted: 2013-09-05
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma
Sponsor: University of Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Renal Cell Carcinoma View